Optimizing Genetic Testing Eligibility Verification for Revenue Cycle Efficiency

The Unique Challenges of Eligibility in Genetic Testing

Genetic testing, encompassing services like hereditary cancer panels, prenatal genetic testing, and pharmacogenomics, frequently involves high-cost procedures and specialized benefits administration. Many payers route these complex services through benefit management organizations (RBMs) such as eviCore or Avalon Healthcare Services, adding layers of complexity to standard eligibility checks. Manual processes often fail to capture these nuances, leading to downstream denials and revenue leakage.

Common Failure Modes in Manual Genetic Testing Eligibility Workflows

• **Stale Eligibility Data:** Coverage verified at scheduling may change by the date of service, especially for high-cost genetic tests scheduled in advance.
• **Misinterpretation of X12 271 Responses:** The complexity of X12 271 benefit responses can lead staff to misread specific benefit categories or in-network status critical for genetic tests.
• **PA Requirement Gaps:** Eligibility checks may not clearly identify prior authorization requirements for specific genetic testing panels, leading to 'PA not on file' denials.
• **Secondary Coverage Misses:** Failure to identify Medicare-secondary-payer status or coordinate of benefits (COB) for dual-coverage patients.
• **Benefit Exhaustion:** Eligibility may show active coverage, but specific benefit categories for genetic testing may have been exhausted, leading to unexpected patient balances.

Klivira's Automated Approach to Genetic Testing Eligibility Verification

Klivira integrates multi-channel eligibility queries to provide a comprehensive view of patient coverage for genetic testing. Our platform initiates checks at key trigger points—patient registration, appointment scheduling, or order entry—to ensure timely and accurate information. We leverage X12 270 submissions via clearinghouses and FHIR Coverage resource retrieval for FHIR-conformant payers, providing a normalized eligibility model across diverse data sources.

Key Automation Features for Genetic Testing Workflows

• **Normalized Eligibility Data:** Klivira parses X12 271 responses and FHIR Coverage data into a consistent model, eliminating ambiguity in active status, plan type, deductible state, and PA requirements specific to genetic testing.
• **EMR Write-Back:** Detailed eligibility information is written back to the EMR, either as a Coverage resource update or a structured note, ensuring clinical and administrative visibility for genetic test orders.
• **PA Workflow Gating:** When eligibility identifies a prior authorization requirement for a planned genetic test, the PA workflow is automatically initiated, closing the critical eligibility → PA detection loop.
• **Re-verification Logic:** For high-cost genetic tests scheduled in advance, Klivira automatically re-verifies eligibility closer to the date of service, catching mid-period coverage changes.
• **Benefit Exhaustion Tracking:** For genetic testing benefit categories with visit or cost caps, Klivira tracks utilization against these limits, surfacing remaining benefits to prevent denials.

Industry Standards and Interoperability for Genetic Testing Eligibility

Klivira's eligibility verification leverages industry standards to ensure robust and future-proof connectivity. We utilize the X12 270/271 transaction set for eligibility inquiry and response, the primary EDI standard. For modern interoperability, we consume FHIR Coverage resources, aligning with initiatives like Da Vinci CRD and PAS, and the CMS-0057-F Patient Access API requirements for member coverage data. This multi-standard approach ensures comprehensive coverage across the payer landscape.